Cargando…

A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression

BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, Linghe, Schmidt, Jens C., Zaug, Arthur J., Ascarrunz, Dante R., Cech, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640169/
https://www.ncbi.nlm.nih.gov/pubmed/26553065
http://dx.doi.org/10.1186/s13059-015-0791-1
_version_ 1782400044678250496
author Xi, Linghe
Schmidt, Jens C.
Zaug, Arthur J.
Ascarrunz, Dante R.
Cech, Thomas R.
author_facet Xi, Linghe
Schmidt, Jens C.
Zaug, Arthur J.
Ascarrunz, Dante R.
Cech, Thomas R.
author_sort Xi, Linghe
collection PubMed
description BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic subunit of the ribonucleoprotein complex. The low expression level of TERT and the lack of adequate antibodies have made it difficult to study telomerase-related processes in human cells. RESULTS: To overcome the low CRISPR-Cas9 editing efficiency at the TERT locus, we develop a two-step “pop-in/pop-out” strategy to enrich cells that underwent homologous recombination (HR). Using this technique, we fuse an N-terminal FLAG-SNAP-tag to TERT, which allows us to reliably detect TERT in western blots, immunopurify it for biochemical analysis, and determine its subcellular localization by fluorescence microscopy. TERT co-localizes detectably with only 5–7 % of the telomeres at a time in S-phase HeLa cells; no nucleolar localization is detected. Furthermore, we extend this approach to perform single base-pair modifications in the TERT promoter; reverting a recurrent cancer-associated TERT promoter mutation in a urothelial cancer cell line results in decreased telomerase activity, indicating the mutation is causal for telomerase reactivation. CONCLUSIONS: We develop a two-step CRISPR-Cas9 genome editing strategy to introduce precise modifications at the endogenous TERT locus in human cell lines. This method provides a useful tool for studying telomerase biology, and suggests a general approach to edit loci with low targeting efficiency and to purify and visualize low abundance proteins. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0791-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4640169
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46401692015-11-11 A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression Xi, Linghe Schmidt, Jens C. Zaug, Arthur J. Ascarrunz, Dante R. Cech, Thomas R. Genome Biol Research BACKGROUND: To facilitate indefinite proliferation, stem cells and most cancer cells require the activity of telomerase, which counteracts the successive shortening of telomeres caused by incomplete DNA replication at the very end of each chromosome. Human telomerase activity is often determined by the expression level of telomerase reverse transcriptase (TERT), the catalytic subunit of the ribonucleoprotein complex. The low expression level of TERT and the lack of adequate antibodies have made it difficult to study telomerase-related processes in human cells. RESULTS: To overcome the low CRISPR-Cas9 editing efficiency at the TERT locus, we develop a two-step “pop-in/pop-out” strategy to enrich cells that underwent homologous recombination (HR). Using this technique, we fuse an N-terminal FLAG-SNAP-tag to TERT, which allows us to reliably detect TERT in western blots, immunopurify it for biochemical analysis, and determine its subcellular localization by fluorescence microscopy. TERT co-localizes detectably with only 5–7 % of the telomeres at a time in S-phase HeLa cells; no nucleolar localization is detected. Furthermore, we extend this approach to perform single base-pair modifications in the TERT promoter; reverting a recurrent cancer-associated TERT promoter mutation in a urothelial cancer cell line results in decreased telomerase activity, indicating the mutation is causal for telomerase reactivation. CONCLUSIONS: We develop a two-step CRISPR-Cas9 genome editing strategy to introduce precise modifications at the endogenous TERT locus in human cell lines. This method provides a useful tool for studying telomerase biology, and suggests a general approach to edit loci with low targeting efficiency and to purify and visualize low abundance proteins. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13059-015-0791-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-11-10 2015 /pmc/articles/PMC4640169/ /pubmed/26553065 http://dx.doi.org/10.1186/s13059-015-0791-1 Text en © Xi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Xi, Linghe
Schmidt, Jens C.
Zaug, Arthur J.
Ascarrunz, Dante R.
Cech, Thomas R.
A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title_full A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title_fullStr A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title_full_unstemmed A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title_short A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
title_sort novel two-step genome editing strategy with crispr-cas9 provides new insights into telomerase action and tert gene expression
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640169/
https://www.ncbi.nlm.nih.gov/pubmed/26553065
http://dx.doi.org/10.1186/s13059-015-0791-1
work_keys_str_mv AT xilinghe anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT schmidtjensc anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT zaugarthurj anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT ascarrunzdanter anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT cechthomasr anoveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT xilinghe noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT schmidtjensc noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT zaugarthurj noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT ascarrunzdanter noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression
AT cechthomasr noveltwostepgenomeeditingstrategywithcrisprcas9providesnewinsightsintotelomeraseactionandtertgeneexpression